We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

Article   Nov 01, 2013

 
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
 
 
Advertisement
 

RELATED ARTICLES

Combating Challenging Separations With Advanced 2D Liquid Chromatography Technologies

Article

Liquid chromatography (LC) systems are the backbone of pharmaceutical and biopharmaceutical laboratories. However, with increasingly complex samples and efficiency pressures, scientists are seeking more confidence in their results. Can innovative two-dimensional LC (2D-LC) systems provide the answer?

READ MORE

Non-Invasive Biomarker Can Track and Verify Senolytic Drug Efficacy

Article

In a new study published in Cell Metabolism, scientists share their discovery of a novel, non-invasive biomarker test that can be utilized to measure and track the performance of senolytic drugs.

READ MORE

The Coronavirus Pandemic

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE